Narrow Your Search

Narrow Your Search

Focus

Publisher

Companies

People

Articles

6,960 Articles
Psychedelic Invest
Psychedelic Invest
/
Jun 21, 2024

What Mindbloom’s Ketamine Study Could Mean for the Psychedelics Industry

Mindbloom’s recent ketamine study, the largest of its kind ever conducted, holds the promise of revolutionizing the treatment of depression and anxiety. As mental health issues continue to affect millions worldwide, innovative approaches like ketamine therapy are gaining attention for their...
Ketamine Psychedelics
DoubleBlind Mag
DoubleBlind Mag
/
Jun 21, 2024

Meow Wolf Is Opening a Meta Movie Theater in LA

Lovers of Burning Man-esque psychedelic spectacles, rejoice: The absurdist art playground known as Meow Wolf is opening a new location in Los Angeles. Expected to arrive in 2026, Meow Wolf’s Los Angeles edition will find its home in a movie theater complex at Howard Hughes LA, a sprawling mall on...
Psychedelics
Psychedelics Today
Psychedelics Today
/
Jun 21, 2024

Spirituality: An Essential Understanding for Psychedelic Integration

Presented by Rev. Lynda Elaine Carré, this free webinar will give attendees an understanding of what spirituality is (and is not), and why it is essential and inseparable from responsible psychedelic integration, as well as teach attendees how to prepare themselves (and their clients) to face...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 21, 2024

What It Really Means to Be a Curandera

As plant medicine and shamanic practices spread throughout the world, many new terms are being introduced to — and sometimes misused by — Westerners. One word that you may have heard if you’re involved with the plant medicine community is curandero or curandera, a term for an Indigenous healer...
Psychedelics Today
Psychedelics Today
/
Jun 21, 2024

Self-Care, Destabilization, and the Holistic Nature of Psychedelics

In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain; and Dr. Michele Cox, DO: current Vital student, veteran, physician, and...
Psychedelics
Psychedelic Invest
Psychedelic Invest
/
Jun 20, 2024

Atai Life Sciences Announces Update on Beckley Psytech’s Phase 1/2a Trial of ELE-101 (IV Psilocin) for Major Depressive Disorder, with Initial Results from Phase 1 and First Patients Dosed in Phase 2a

NEW YORK and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced an update on Beckley Psytech’s Phase 1/2a trial of...
Psychedelic Invest
Psychedelic Invest
/
Jun 20, 2024

Numinus Wellness Announces Strategic Acquisition of MedBright AI

VANCOUVER, BC, June 20, 2024 /CNW/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX: NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies,...
Psychedelics Today
Psychedelics Today
/
Jun 20, 2024

Expanding Psychedelic Clinical Trials to LGBTQ+ Populations

Explore how expanding psychedelic clinical trials to include LGBTQ+ populations can address mental health disparities and foster inclusivity. This article underscores the urgent need for research that encompasses unique minority stressors, aiming for equitable and effective mental health...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 20, 2024

Embracing the Liminal Space As An Intersex Activist and Psychedelics Advocate

I find great pride in being visible, but deciding to publish this feels vulnerable. It’s a new type of exposure. Not that exposing myself is a new phenomenon for me, as an intersex woman who’s become accustomed to speaking about my genitals, medical history, and violations of my consent on a...
Ayahuasca Psychedelics
DoubleBlind Mag
DoubleBlind Mag
/
Jun 20, 2024

Colombia’s President Admits to Drinking Ayahuasca

Most politicians prefer not to divulge the details of their drug use or psychedelic histories. Gustavo Petro, the president of Colombia, is not one of those political leaders, as he recently revealed that he’s twice taken ayahuasca, a visionary Amazonian brew also known as yagé. “The president...
Ayahuasca
Psychedelic Invest
Psychedelic Invest
/
Jun 20, 2024

MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the completion of the End-of-Phase 2 (EOP2) meeting with the U.S. Food and Drug...
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Jun 20, 2024

Numinus plans to buy MedBright AI in all-stock deal

Numinus Wellness Inc.  (TSX: NUMI) (OTCQX: NUMIF) has signed a letter of intent to buy MedBright AI Investments Inc. in an all-stock deal. In addition to the acquisition, Numinus said it will change its name to Numinus Intelligence, but keep its stock symbol the same. “This acquisition is the...
MDMA
DoubleBlind Mag
DoubleBlind Mag
/
Jun 20, 2024

“A Wild West”: How Amanita muscaria Gummies Mislead Buyers

“Find white soft stalks with spotted hats,” instructs a deity, according to a legend of the indigenous Koryak people of the Russian far east. “These are the spirits [of the Amanita mushroom].” In the myth, the protagonist is able to perform superhuman feats after consuming the red and white,...
Psychedelic Invest
Psychedelic Invest
/
Jun 20, 2024

Psychedelic Legislative Trends in 2024: A Detailed Overview

The first half of 2024 has been captivating for several reasons. Oregon’s regulated access program has been operational for eighteen months, serving thousands with psilocybin services. Meanwhile, Colorado is navigating the complexities of decriminalizing multiple sacred plants and establishing a...
Psilocybin MDMA Psychedelics
Psychedelic Invest
Psychedelic Invest
/
Jun 20, 2024

Psychedelics and Their Potential to Alleviate Death Anxiety

The therapeutic potential of psychedelics is increasingly being recognized as researchers delve into their ability to manage symptoms of various mental health conditions and enhance overall well-being. Recent research has uncovered that psychedelic experiences can significantly reduce death anxiety,...
Psychedelic Invest
Psychedelic Invest
/
Jun 20, 2024

Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD Treatment

Vancouver, Canada, June 20, 2024 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 19, 2024

Can Psychedelics Treat Long-Covid’s Debilitating Symptoms? 

Long Covid is one of the biggest healthcare challenges facing the post-pandemic world, with scientists yet to find effective or broad treatment options for the chronic and often debilitating condition. While it might sound like a stretch at first, a movement to study whether psychedelics can treat...
MDMA Psychedelics
DoubleBlind Mag
DoubleBlind Mag
/
Jun 19, 2024

Shrooms Won’t Make You Believe in God, But They Might Convince You That Robots Have Feelings

A new study by Johns Hopkins University researchers on the effects of psychedelics suggests that—contrary to earlier evidence—a single psilocybin experience isn’t likely to make an atheist believe in God or dispel someone’s sense of free will. It may, however, inspire the belief that...
LSD
Psychedelic Invest
Psychedelic Invest
/
Jun 19, 2024

Relmada Therapeutics Announced Publication of Results from the Phase 3 Reliance I Study of REL-1017 in The Journal of Clinical Psychiatry

CORAL GABLES, Fla., June 18, 2024 /PRNewswire/ — Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced the publication of REL-1017 clinical data from the Reliance I Study in the peer-reviewed...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 19, 2024

5 of the Best Mushroom Grow Bags For Beginners

What if you could grow natural psychedelics in the comfort of your own home? Well, there’s a mushroom grow bag for that. If you’re new to growing, or simply want a lower maintenance option, many retailers sell all-in-one bags designed to provide the ideal environment for mushrooms to thrive that...
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Jun 19, 2024

Mindbloom publishes the results of largest ketamine study to date

Privately owned psychedelic therapy company Mindbloom announced the positive findings of the largest peer-reviewed study regarding ketamine therapy and psychedelic medicine. The study, published in the Journal of Affective Disorders, was authored by psychiatrists and researchers from Johns...
Psychedelic Invest
Psychedelic Invest
/
Jun 19, 2024

Cybin to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic treatment options, is pleased to announce that Doug Drysdale,...
DMT
Psychedelics - Green Market Report
Psychedelics - Green Market Report
/
Jun 18, 2024

Relmada Therapeutics publishes results of depression drug trial

Relmada Therapeutics Inc. (Nasdaq: RLMD) announced the publication of “promising” REL-1017 clinical data from the Reliance I Study in the peer-reviewed journal, The Journal of Clinical Psychiatry. “The overall results from this trial are clearly consistent with the evidence, produced by the...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 18, 2024

LSD Is on Deck As New Treatment for PMS and PMDD

We’ve all heard about the studies looking into psychedelics and mental health. But what about using psychedelics for women’s health issues? As in, specifically working with psychedelics to treat the hormonal discomfort of a woman’s moon cycle? If you’re a bleeding psychonaut, you probably...
LSD
Psilocybin Alpha
Psilocybin Alpha
/
Jun 18, 2024

In Conversation: Joanna Kempner, Author of “Psychedelic Outlaws: The Movement Revolutionizing Modern Medicine”

Tuesday, June 4th was a day that some psychedelic medicine advocates might hope to forget, as an FDA advisory committee dealt a blow to Lykos Therapeutics’ MDMA-assisted therapy. But, in some much brighter news, it was also the day that American sociologist Dr. Joanna Kempner published her...
Psychedelics Today
Psychedelics Today
/
Jun 18, 2024

An Inside Look at the FDA and Early Drug Development

In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA. With Lykos Therapeutics working towards FDA approval of MDMA-assisted psychotherapy for PTSD, ICER...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 17, 2024

Does Internal Family Systems Therapy Implant the Belief of Demons and Entities into Clients?

Robert Falconer is refreshingly honest.  He’s a leading figure in Internal Family Systems (IFS), which is the second-most-popular therapeutic modality among underground psychedelic guides (according to a forthcoming survey by the University of Michigan — the most popular modality is Somatic...
DMT
DoubleBlind Mag
DoubleBlind Mag
/
Jun 17, 2024

LAX Is the World’s Largest Hub for Drug Trafficking, Law Enforcement Says

Certain regions of the world are historic corridors for drug trafficking, such as cocaine in Central and South America, opium and heroin in Southeast Asia’s Golden Triangle, and hashish and cannabis in the Middle East, Tibet, and Nepal. But a surprising city has emerged as the drug smuggling...
Psychedelics
DoubleBlind Mag
DoubleBlind Mag
/
Jun 17, 2024

Did Viking Berserkers Take Magic Mushrooms?

Using drugs to fight wars isn’t new. Headlines today focus on soldiers healing from PTSD with compounds like MDMA, but mixing substances and combat is something of a tradition: Between Arabs with hashish, Nazis on methamphetamines, and the United States military’s Go pills (Modafinil), the...
Psilocybin
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

Psychedelic Retreats Market Set to Cross $1 Trillion By 2027

The market for psychedelic retreats is on a remarkable trajectory, with projections indicating it will surpass the $1 trillion mark by 2027. This anticipated milestone reflects the rapid expansion and increasing acceptance of psychedelic therapy as an effective treatment for various mental health...
MDMA
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

Largest Study of Psychedelic Medicine, with 11,441 Mindbloom Clients, Demonstrates Effectiveness and Safety of Guided At-Home Ketamine Therapy

AUSTIN, Texas, June 14, 2024 /PRNewswire/ — Mindbloom, the leading provider of psychedelic therapy, announced today the findings of the largest peer-reviewed study in the history of ketamine therapy and psychedelic medicine. The study was published in the Journal of Affective Disorders, and...
Ketamine
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

Lykos Therapeutics Addresses Concerns Over MDMA Treatment for PTSD

A week after an FDA committee voted against recommending midomafetamine (MDMA) treatment for post-traumatic stress disorder (PTSD), Lykos Therapeutics is working to clarify the situation and address concerns that have emerged in the broader conversation. This effort comes in the wake of significant...
MDMA
Psychedelic Invest
Psychedelic Invest
/
Jun 14, 2024

UC Berkeley’s Groundbreaking Study Exploring Psilocybin’s Effects on Perception

The UC Berkeley Center for the Science of Psychedelics has embarked on an unprecedented study to explore why psilocybin, a psychoactive compound found in certain mushrooms, alters visual perception in humans. This investigation represents the university’s first human trials involving a Schedule I...
Psilocybin Psychedelics
Psilocybin Alpha
Psilocybin Alpha
/
Jun 14, 2024

Pα+ Psychedelic Bulletin #164: Lykos Dominates News Cycle; EPIsoDE Trial Readout; EU Drug Report Discusses Psychedelics; DEA Should Improve RFRA Petition Process; Other News

Gosh, it’s been a busy few weeks! Our news cycle has been dominated by Lykos Therapeutics-related stories, from ICER’s report and panel meeting through to FDA’s Advisory Committee meeting and yesterday’s patent-related news. Elsewhere in the psychedelics field, things have been a little...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 14, 2024

14 of the Very Best Mushroom Memes

Mushrooms have a good sense of humor. They not only make you see the absurdity of our everyday reality but can also bring out your playful inner child. While shroom trips can be dark, they can also be full of giggle fits—and there are many laughs to be had about mushrooms, even while sober. Not...
DoubleBlind Mag
DoubleBlind Mag
/
Jun 14, 2024

Psychedelic Visuals Are Produced in the Backs of Our Eyeballs, New Theory Suggests

The psychedelic experience amounts to a mesmerizing, stupefying, and at times terrifying, divine ride into the cosmos and back. Naturally, the specifics vary wildly, depending on set, setting, and the psychedelic itself – plus the quantity consumed. But when it comes to visual hallucinations,...
DMT